FIELD: medicine, experimental oncology.
SUBSTANCE: the present innovation deals with introducing ribonuclease, moreover, as ribonuclease one should apply pancreatic RNase A at concentration of (3.5-7.0)10-4 mg/kg animal body weight. Pancreatic RNase A should be injected intramuscularly, daily, about 8-10 injections/course. The innovation enables to considerably decrease the dosage of ribonuclease and exclude side complications.
EFFECT: higher efficiency of therapy.
5 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT BASED ON POLYSACCHARIDES FROM CALAMUS ROOT ENHANCING OF ANTI-TUMOR AND ANTI-METASTASIS ACTIVITY OF CYTOSTATIC PREPARATIONS | 2005 |
|
RU2308285C2 |
| METHOD FOR ENHANCING OF CYCLOPHOSPHAN ANTITUMOR AND ANTIMETASTATIC ACTIVITY IN EXPERIMENT | 2004 |
|
RU2270682C2 |
| AGENTS IMPROVING ANTICANCER AND ANTIMETASTATIC ACTIVITY OF CYTOSTATICS | 2011 |
|
RU2471496C1 |
| PREPARATION INCREASING ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF CYCLOPHOSPHAN | 2002 |
|
RU2225720C1 |
| ANGIOGENESIS INHIBITOR, ANTI-ANGIOGENIC PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT OF MALIGNANT NEOPLASM | 2005 |
|
RU2287341C1 |
| CORRECTIVE AGENT FOR PARANEOPLASTIC DAMAGES AND TOXIC EFFECTS OF CYTOSTATIC POLYCHEMOTHERAPY | 2008 |
|
RU2385324C1 |
| METHOD FOR TREATING MALIGNANT NEOPLASMS | 2006 |
|
RU2320364C1 |
| AGENT FOR CORRECTING CYTOTOXIC EFFECTS OF PARANEOPLASTIC PROCESSES AND CHEMOTHERAPY SHOWING ANTICANCER ACTIVITY | 2011 |
|
RU2447888C1 |
| AGENT WITH ANTITUMOR AND ANTIMETASTATIC ACTIVITY, INCREASING ANTIMETASTATIC EFFECT OF CYCLOPHOSPHAN | 2015 |
|
RU2578457C1 |
| N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
